MNDL Bio
MNDL Bio
Synthetic biology startup optimizing gene expression for food and biotech applications.
Rate
About
MNDL Bio is a synthetic biology company focused on reducing the cost and production time for food and biotechnology applications. They achieve this through advanced computational platforms designed to optimize gene expression, enabling more efficient and scalable biological manufacturing.
Technology stack
detected 2026-06-24Email
Microsoft 365
Stack
Wix
Observability
Sentry
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does MNDL Bio do?
MNDL Bio is a synthetic biology company focused on reducing the cost and production time for food and biotechnology applications. They achieve this through advanced computational platforms designed to optimize gene expression, enabling more efficient and scalable biological manufacturing.
How much funding has MNDL Bio raised?
MNDL Bio has raised a total of $2M in funding. The most recent round on record is Pre-Seed.
Where is MNDL Bio headquartered?
MNDL Bio is headquartered in San Francisco, United States.
When was MNDL Bio founded?
MNDL Bio was founded in 2023.
What industry does MNDL Bio operate in?
MNDL Bio operates in Life Sciences, Synthetic Biology, Genetics, Food, Biotech, Genomics.
How many employees does MNDL Bio have?
MNDL Bio has approximately 10 people on record.